Belkıs Narlı

Belkıs Narlı

Auto-generated profile, based on publicly available information

Belkıs Narlı

GAZI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES, DEPARTMENT OF MEDICAL BIOCHEMISTRY

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 November 2023 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
NYNiyazi Samet Yilmaz
Niyazi Samet Yilmaz
BŞBayram Şen
Bayram Şen
BABurak Arslan
Burak Arslan
TBTuba Saadet Deveci Bulut
Tuba Saadet Deveci Bulut
BNBelkis Narli
Belkis Narli
OGOzlem Gulbahar
Ozlem Gulbahar
Objectives: Autoverification (AV) is releasing laboratory results using predefined rules. AV standardizes the verification of laboratory results, improves turnaround time (TAT), detects errors in the total test process, and enables effective use of laboratory staff. In this study, we aimed to evaluate the outcomes of implementing the AV in a tertiary hospital. Methods: The study was performed in Gazi University Health Research and Application Hospital, Core Biochemistry Laboratory, between August 2017 and October 2019. Step by step, AV algorithms were designed and implemented via middleware for 29 clinical biochemistry tests. A comprehensive validation was performed before the AV system was run. Initially, AV system was tested with datasets and simulated patients (dry testing). Next, samples that may violate AV rules were tested anonymously with no-named trial barcodes (wet testing). Finally, validation of the system was performed with real patients, while the AV was running in the background but not active (i.e., while the manual verification was still going on). After all these steps were successful, the system was started. Results: In the daytime, AV rates were ≥75 % for 23 of 29 tests. In night-shift, AV rates were ≥70 % for 16 of 25 tests. Report-based performance was found 26 % for daytime. TAT in the daytime decreased after AV implementation. Conclusions: Although this is the first time we have implemented the AV, a significant percentage of the tests have been verified. However, approaches that will increase the percentage of report-based verification will enhance the efficiency of autoverification.

21 December 2022 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
ETEzgi Turgut
Ezgi Turgut
HÖHalis Özdemir
Halis Özdemir
BNBelkıs Narlı
Belkıs Narlı
CYCanan Yılmaz
Canan Yılmaz
MBMerih Bayram
Merih Bayram
DKDeniz Karcaaltıncaba
Deniz Karcaaltıncaba

22 May 2025 in Sağlık Bilimlerinde Değer
Verified
Journal Article
Open access
PDF file
FÖFazıl Deniz Özer
Fazıl Deniz Özer
KKKardelen Kocaman Kalkan
Kardelen Kocaman Kalkan
BNBelkıs Narlı
Belkıs Narlı
CYCanan Yılmaz
Canan Yılmaz
Aim: With the rising prevalence of Metabolic Syndrome (MetS), antioxidant therapies for managing oxidative stress are gaining attention. Fructose, a major metabolic stressor and a prevalent sweetener in processed foods, plays a significant role in this condition. This study evaluates quercetin's effects on MetS components, specifically its ability to alleviate oxidative stress in liver tissue within a fructose-induced MetS model. Material and Methods: 24 Sprague-Dawley rats were randomly divided into four groups: control, fructose, quercetin, and fructose+quercetin. Quercetin (15 mg/kg/day) was administered via gavage, and a 20% fructose solution was provided in drinking water over 10 weeks. Key metabolic parameters, including body weight, blood pressure, serum glucose, triglycerides, insulin levels, and insulin resistance, were assessed to confirm MetS. Liver tissue was analyzed for oxidative stress markers, including malondialdehyde (MDA), advanced oxidation protein products (AOPP), nitric oxide (NO), total antioxidant status (TAS), total oxidant status (TOS), and the oxidative stress index (OSI). Results: Fructose administration successfully induced key metabolic syndrome components, such as obesity, hypertension, hypertriglyceridemia, hyperglycemia, and insulin resistance. Quercetin significantly reduced fructose-induced hypertension and insulin resistance, though its effects on obesity, hyperglycemia, and hypertriglyceridemia were limited. Fructose exposure markedly elevated liver MDA, AOPP, and TOS levels, with nonsignificant increases in NO and TAS. Co-administration of quercetin with fructose resulted in significantly higher MDA levels compared to controls, while AOPP levels were notably reduced. Conclusion: At the administered dose, quercetin showed limited efficacy in mitigating fructose-induced lipid peroxidation; however, it displayed notable antioxidant activity by modulating protein oxidation and NO levels. These findings provide valuable insights into the pathogenesis of metabolic syndrome and suggest potential therapeutic avenues for targeting its underlying components.